Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month

02:20 PM EDT, 08/26/2026 (MT Newswires) -- Revolution Medicines' (RVMD) once-daily oral Rasonque tablets for the treatment of metastatic pancreatic cancer are available in the US at a price of $39,800 for a 30-day supply, the company said Wednesday in a regulatory filing. The US Food and Drug Administration approved Rasonque for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. Price: 215.95, Change: +4.57, Percent Change: +2.16